Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
16 December 2017 |
Main ID: |
NCT01209416 |
Date of registration:
|
24/09/2010 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
The Effect of Pharmacological Antilipolysis on the Metabolic Effects of Ghrelin
|
Scientific title:
|
The Effect of Pharmacological Antilipolysis on the Metabolic Effects of Ghrelin |
Date of first enrolment:
|
June 2012 |
Target sample size:
|
8 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT01209416 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Basic Science. Masking: Triple (Participant, Care Provider, Investigator).
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Denmark
| | | | | | | |
Contacts
|
Name:
|
Jens Otto L Jørgensen, Professor |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
University Hospital of Aarhus |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- males with hypopituitarism in regard to growth hormone and ACTH in stabile treatment
regime
- age 18-65
- BMI 20-35
Exclusion Criteria:
- abuse of alcohol
- malign disease
- medication other than that expected for hypopituitarism
- known disease other than hypopituitarism
- participation in isotope investigations the last 6 months
Age minimum:
18 Years
Age maximum:
65 Years
Gender:
Male
|
Health Condition(s) or Problem(s) studied
|
Insulin Resistance
|
Hypopituitarism
|
Metabolism
|
Intervention(s)
|
Drug: Ghrelin
|
Drug: Acipimox
|
Other: Placebo
|
Primary Outcome(s)
|
Effects of ghrelin during basal and hyperinsulinemic conditions
[Time Frame: 5 hours investigation day]
|
Secondary ID(s)
|
M-2010-0157
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|